<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content


So, whether you’re planning on designing a clinical program for COVID-19 research or looking to overcome challenges that the virus has created for your current trials, the next steps are vital.
We’re here to help through a range of services and software solutions.


Trial Disruptions

Given the range of potential clinical trial disruptions due to COVID-19, Cytel’s experienced team of statisticians and data scientists can work with you to identify any potential challenges and complications you may be facing.  Our team of experts can support you by providing a range of solutions to overcome your toughest challenges and get your trial back on track

Cytel provides: 

  • Updated Statistical Analysis Plans
  • Solutions to Sparse or Missing Data
  • Examining Endpoint Selection
  • Ensuring Proper Documentation
  • Coordinating DMCs and Unplanned Interim Looks


Cytel software helps you deliver the impossible

You’ve been asked to conduct research at an unprecedented rate – to deliver the impossible.  Cytel’s software portfolio gives you adaptive, Bayesian, and exact tools to go fast and learn.

Design Faster, Smarter COVID-19 Trials: manage uncertainty, improve efficiency, and increase the likelihood of technical success with East. 

  • Design appropriately for small or skewed data 
  • Account for uncertainty in the therapeutic effect 
  • Progress confidently despite imperfect data 
  • Explore more therapies in less time with fewer patients 

Accurately Analyze Imperfect COVID-19 Data: Rethink how you leverage data to draw conclusions with the Xact portfolio.

  • Accurately analyze small or skewed data
  • Leverage historical data

Accelerate Defensible Decisions for Faster COVID-19 Development: Cytel’s OKGO helps you move faster and smarter with aBayesian frameworkfor structuring decisions in advance

  • Reduce Bias 
  • Increase consistency 
  • Accelerate data review


As the race to find a solution to the coronavirus pandemic intensifies a team of data scientists can become important partners on the journey. 

Cytel provides:

  • Meta-analysis and modelling using Real World Evidence
  • Consultations on umbrella, basket and platform trials
  • Bayesian network analysis
  • Synthetic and External Control Arm Construction
  • Real World Data through the COVID-19 Trial Tracker


Quickly and Confidently Address COVID-19 Disruptions

You had a strong plan, but the COVID-19 outbreak is disrupting trials globally.  Get your enrollment forecast and data analysis plan back on track with EnForeSys and StatXact.

  • Confidently conquer enrollment uncertainty: EnForeSys is a simulation tool that simplifies complex modeling, accounts for uncertainty and seasonality, and extracts insights from your prior data so you can more accurately set expectations around your recruitment timelines.


  • Accurately analyze sparse data: When data is missing, asymptotic results given by traditional methods may not be valid. StatXact uses exact methodologies to accurately analyze sparse data. 
  • Adapt stratification plans: StatXact enables the design and analysis of data with stratification if data from only certain centers, geographies, or groups are available.

Contact Us

Fill in the form below to get in touch